What is SonarMD?
SonarMD operates at the intersection of digital health and chronic disease management, specifically targeting inflammatory bowel disease (IBD). The platform leverages sophisticated tools to provide continuous patient monitoring and facilitate timely access to expert medical support. By partnering with health plans and healthcare providers, SonarMD aims to deliver personalized care pathways designed to improve patient well-being and achieve cost efficiencies within the healthcare system. Their approach emphasizes preventative care, empowering both patients and providers to manage IBD more effectively and reduce the incidence of hospitalizations.
How much funding has SonarMD raised?
SonarMD has raised a total of $13M across 2 funding rounds:
Series A
$10M
Private Equity
$3M
Series A (2018): $10M with participation from BCBS Venture Partners and Arboretum Ventures
Private Equity (2026): $3M, investors not publicly disclosed
Key Investors in SonarMD
BCBS Venture Partners
BCBS Venture Partners is a venture capital firm that invests in companies of strategic relevance to Blue Cross and Blue Shield Plans, managing over $500 million across three funds. They focus on promising, emerging companies that can enhance healthcare solutions.
Arboretum Ventures
Arboretum Ventures is a healthcare venture capital firm with extensive experience in early-stage healthcare startups. They focus on innovative solutions that improve patient outcomes and reduce costs, with a portfolio spanning medical devices, life science tools, and tech-enabled care delivery.
What's next for SonarMD?
With the recent influx of major strategic investment, SonarMD is poised for significant expansion and further development of its innovative digital health solutions. The company's focus on improving patient outcomes and reducing healthcare costs in the IBD sector aligns with growing industry trends towards value-based care and preventative health strategies. This capital infusion is anticipated to fuel advancements in their monitoring technology, broaden their partnership network with health plans and providers, and enhance their service offerings. SonarMD's trajectory suggests a continued commitment to becoming a leader in chronic disease management through data-driven, patient-centric care.
See full SonarMD company page
